Literature DB >> 29081872

PSEUDO-VALUE APPROACH FOR CONDITIONAL QUANTILE RESIDUAL LIFETIME ANALYSIS FOR CLUSTERED SURVIVAL AND COMPETING RISKS DATA WITH APPLICATIONS TO BONE MARROW TRANSPLANT DATA.

Kwang Woo Ahn1, Brent R Logan1.   

Abstract

Quantile residual lifetime analysis is conducted to compare remaining lifetimes among groups for survival data. Evaluating residual lifetimes among groups after adjustment for covariates is often of interest. The current literature is limited to comparing two groups for independent data. We propose a pseudo-value approach to compare quantile residual lifetimes given covariates between multiple groups for independent and clustered survival data. The proposed method considers clustered event times and clustered censoring times in addition to independent event times and censoring times. We show that the method can also be used to compare multiple groups on the cause specific residual life distribution in the competing risk setting, for which there are no current methods which account for clustering. The empirical Type I errors and statistical power of the proposed study are examined in a simulation study, which shows that the proposed method controls Type I errors very well and has higher power than an existing method. The proposed method is illustrated by a bone marrow transplant data set.

Entities:  

Keywords:  clustered data; pseudo–value; residual lifetime

Year:  2016        PMID: 29081872      PMCID: PMC5656291          DOI: 10.1214/16-AOAS927

Source DB:  PubMed          Journal:  Ann Appl Stat        ISSN: 1932-6157            Impact factor:   2.083


  21 in total

1.  Competing risks regression for clustered data.

Authors:  Bingqing Zhou; Jason Fine; Aurelien Latouche; Myriam Labopin
Journal:  Biostatistics       Date:  2011-10-31       Impact factor: 5.899

2.  Doubly Robust Learning for Estimating Individualized Treatment with Censored Data.

Authors:  Y Q Zhao; D Zeng; E B Laber; R Song; M Yuan; M R Kosorok
Journal:  Biometrika       Date:  2015-03-01       Impact factor: 2.445

3.  Efficient resampling methods for nonsmooth estimating functions.

Authors:  Donglin Zeng; D Y Lin
Journal:  Biostatistics       Date:  2007-10-08       Impact factor: 5.899

4.  Score test of homogeneity for survival data.

Authors:  D Commenges; P K Andersen
Journal:  Lifetime Data Anal       Date:  1995       Impact factor: 1.588

5.  Long-term survival after transplantation of unrelated donor peripheral blood or bone marrow hematopoietic cells for hematologic malignancy.

Authors:  Mary Eapen; Brent R Logan; Fredrick R Appelbaum; Joseph H Antin; Claudio Anasetti; Daniel R Couriel; Junfang Chen; Richard T Maziarz; Philip L McCarthy; Ryotaro Nakamura; Voravit Ratanatharathorn; Ravi Vij; Richard E Champlin
Journal:  Biol Blood Marrow Transplant       Date:  2014-09-22       Impact factor: 5.742

6.  Conditional quantile residual lifetime models for right censored data.

Authors:  Cunjie Lin; Li Zhang; Yong Zhou
Journal:  Lifetime Data Anal       Date:  2014-01-17       Impact factor: 1.588

7.  The analysis of failure times in the presence of competing risks.

Authors:  R L Prentice; J D Kalbfleisch; A V Peterson; N Flournoy; V T Farewell; N E Breslow
Journal:  Biometrics       Date:  1978-12       Impact factor: 2.571

8.  Marginal models for clustered time-to-event data with competing risks using pseudovalues.

Authors:  Brent R Logan; Mei-Jie Zhang; John P Klein
Journal:  Biometrics       Date:  2011-03       Impact factor: 2.571

9.  Life expectancy in patients surviving more than 5 years after hematopoietic cell transplantation.

Authors:  Paul J Martin; George W Counts; Frederick R Appelbaum; Stephanie J Lee; Jean E Sanders; H Joachim Deeg; Mary E D Flowers; Karen L Syrjala; John A Hansen; Rainer F Storb; Barry E Storer
Journal:  J Clin Oncol       Date:  2010-01-11       Impact factor: 44.544

10.  ANALYSIS ON CENSORED QUANTILE RESIDUAL LIFE MODEL VIA SPLINE SMOOTHING.

Authors:  Yanyuan Ma; Ying Wei
Journal:  Stat Sin       Date:  2012-01-01       Impact factor: 1.261

View more
  1 in total

1.  A semiparametric modeling approach for analyzing clinical biomarkers restricted to limits of detection.

Authors:  Sandipan Dutta; Susan Halabi
Journal:  Pharm Stat       Date:  2021-04-14       Impact factor: 1.894

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.